Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes

Aging

Volumn 2, Issue 11, 2010, Pages 867-874

  Gadalla, Shahinaz M ^a   Cawthon, Richard ^b   Giri, Neelam ^a   Alter, Blanche P ^a   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow failure; Correlation; Dyskeratosis congenita; Telomere

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLACKFAN DIAMOND ANEMIA; CHEEK; CHILD; CYTOLOGY; DYSKERATOSIS CONGENITA; FEMALE; FIBROBLAST; GENETICS; HUMAN; MALE; METABOLISM; MOUTH MUCOSA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHYSIOLOGY; TELOMERE;

ADOLESCENT; ADULT; ANEMIA, DIAMOND-BLACKFAN; CHEEK; CHILD; DYSKERATOSIS CONGENITA; FEMALE; FIBROBLASTS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; MALE; MOUTH MUCOSA; TELOMERE; YOUNG ADULT;

EID: 79952733859     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100235     Document Type: Article

References (36)

1. Rodier F, Kim SH, Nijjar T, Yaswen P, Campisi J. Cancer and aging: the importance of telomeres in genome maintenance. Int J Biochem Cell Biol. 2005; 37: 977-990.
2. Aviv A. The epidemiology of human telomeres: faults and promises. J Gerontol A Biol Sci Med Sci. 2008; 63: 979-983.
3. Aubert G and Lansdorp PM. Telomeres and aging. Physiol Rev. 2008; 88: 557-579.
4. Savage SA and Alter BP. Dyskeratosis congenita. Hematol Oncol Clin North Am. 2009; 23: 215-231.
5. Vulliamy TJ, Knight SW, Mason PJ, Dokal I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis. 2001; 27: 353-357.
6. Kirwan M and Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim Biophys Acta. 2009; 1792: 371-379.
7. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc. 2006; 1: 2365-2376.
8. Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood. 2007; 110: 1439-1447.
9. Du HY, Pumbo E, Ivanovich J, An P, Maziarz RT, Reiss UM et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood. 2009; 113: 309-316.
10. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JC, Gordon-Smith EC. Progressive telomere shortening in aplastic anemia. Blood. 1998; 91: 3582-3592.
11. Li X, Leteurtre F, Rocha V, Guardiola P, Berger R, Daniel MT et al. Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia. Br J Haematol. 2003; 120: 836-845.
12. Thornley I, Dror Y, Sung L, Wynn RF, Freedman MH. Abnormal telomere shortening in leucocytes of children with Shwachman-Diamond syndrome. Br J Haematol. 2002; 117: 189-192.
13. Pavesi E, Avondo F, Aspesi A, Quarello P, Rocci A, Vimercati C et al. Analysis of telomeres in peripheral blood cells from patients with bone marrow failure. Pediatr Blood Cancer. 2009; 53: 411-416.
14. Butler MG, Tilburt J, DeVries A, Muralidhar B, Aue G, Hedges L et al. Comparison of chromosome telomere integrity in multiple tissues from subjects at different ages. Cancer Genet Cytogenet. 1998; 105: 138-144.
15. Friedrich U, Griese E, Schwab M, Fritz P, Thon K, Klotz U. Telomere length in different tissues of elderly patients. Mech Ageing Dev. 2000; 119: 89-99.
16. Mondello C, Petropoulou C, Monti D, Gonos ES, Franceschi C, Nuzzo F. Telomere length in fibroblasts and blood cells from healthy centenarians. Exp Cell Res. 1999; 248: 234-242.
17. Thomas P, O' Callaghan NJ, Fenech M. Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev. 2008; 129: 183-190.
18. Meeker AK, Hicks JL, Iacobuzio-Donahue CA, Montgomery EA, Westra WH, Chan TY et al. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res. 2004; 10: 3317-3326.
19. Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S et al. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology. 2004; 40: 80-86.
20. O'Sullivan JN, Bronner MP, Brentnall TA, Finley JC, Shen WT, Emerson S et al. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet. 2002; 32: 280-284.
21. Liu X, Bao G, Huo T, Wang Z, He X, Dong G. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci. 2009; 100: 1300-1305.
22. Prescott J, McGrath M, Lee IM, Buring JE, De V, I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer. 2010; 116: 4275-4282.
23. Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell. 2009; 8: 405-413.
24. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005; 26: 1263-1271.
25. Hewakapuge S, van Oorschot RA, Lewandowski P, Baindur-Hudson S. Investigation of telomere lengths measurement by quantitative real-time PCR to predict age. Leg Med (Tokyo). 2008; 10: 236-242.
26. Takubo K, Izumiyama-Shimomura N, Honma N, Sawabe M, Arai T, Kato M et al. Telomere lengths are characteristic in each human individual. Exp Gerontol. 2002; 37: 523-531.
27. Westin ER, Chavez E, Lee KM, Gourronc FA, Riley S, Lansdorp PM et al. Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts. Aging Cell. 2007; 6: 383-394.
28. Gourronc FA, Robertson M, Herrig AK, Lansdorp PM, Goldman FD, Klingelhutz AJ. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC. Exp Dermatol. 2010; 19: 279-288.
29. Armanios M. Syndromes of Telomere Shortening. Annu Rev Genomics Hum Genet. 2009; 10: 45-61.
30. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990; 346: 866-868.
31. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 1993; 52: 661-667.
32. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 1992; 89: 10114-10118.
33. Thibeault SL, Glade RS, Li W. Comparison of telomere length of vocal folds with different tissues: a physiological measurement of vocal senescence. J Voice. 2006; 20: 165-170.
34. Nakamura K, Izumiyama-Shimomura N, Sawabe M, Arai T, Aoyagi Y, Fujiwara M et al. Comparative analysis of telomere lengths and erosion with age in human epidermis and lingual epithelium. J Invest Dermatol. 2002; 119: 1014-1019.
35. Alter BP, Giri N, Savage SA, Peters J, Loud JT, Leathwood L et al. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Hemat. 2010; 150: 179-88.
36. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009; 37: e21.